Page last updated: 2024-10-31

nabumetone and Erosive Duodenitis

nabumetone has been researched along with Erosive Duodenitis in 1 studies

Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.

Research Excerpts

ExcerptRelevanceReference
"The objective of this endoscopic, double-blind study was to evaluate the gastric tolerability of nabumetone, a novel nonsteroidal anti-inflammatory drug, compared with naproxen in patients with rheumatoid arthritis."5.08Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients. ( Bianchi Porro, G; Caruso, I; Imbesi, V; Montrone, F; Petrillo, M, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bianchi Porro, G1
Montrone, F1
Petrillo, M1
Caruso, I1
Imbesi, V1

Trials

1 trial available for nabumetone and Erosive Duodenitis

ArticleYear
Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients.
    The American journal of gastroenterology, 1995, Volume: 90, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Butanones; Double-Blind Method; Duod

1995